Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pharming completes rhC1INH dossier for compassionate use filings

Jan. 3, 2006

MicroIslet raises funds through sale of common stock

Jan. 3, 2006

New agents for endocrine-related disorders disclosed in recent patent literature

Jan. 3, 2006

Amylin acquires Ohio facility to manufacture exenatide LAR

Jan. 3, 2006

New histamine H3 receptor ligands emerge from Banyu R&D

Jan. 2, 2006

Bexel Pharmaceuticals presents results on a novel antiobesity compound

Dec. 30, 2005

TRPV5: An essential Ca2+ transporter in osteoclastic bone resorption

Dec. 30, 2005

Kissei and JCR sign joint research agreement for JR-013

Dec. 30, 2005

Benefit of eculizumab in paroxysmal nocturnal hemoglobinuria seen at 3 years

Dec. 29, 2005

Vildagliptin safely lowers HbA1c levels in patients with type 2 diabetes

Dec. 29, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...